Bixiye
upcoming-policies-effective-january-30-2023.pdf
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1221 - 1230 ee natiijooyinka 3611
Bixiye
Vtama (tapinarof) - Medicaid
Prior Authorization
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Camzyos - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Radicava (edaravone) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2025
Bixiye
Vijoice (alpelisib) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Vijoice (alpelisib) - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
QP99-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 15, 2023
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Bixiye
QP98-22 Commercial Pharmacy Benefit Exclusion for Cimerli™, Skysona®, Spevigo®, and Xenpozyme™
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Bixiye
QP97-22 Update for New to Market Medical Drugs: etranacogene dezaparvovec
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022
Bixiye
QP100-22 Service Area Expansion for Minnesota Health Care Programs (MHCP)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 23, 2022